EMP1 and breast cancer: Gulisa demonstrated that EMP1 can be used as a reliable marker to distinguish between the two most common histological types of breast cancer: invasive ductal carcinoma and lobular carcinoma, and that the mRNA expression of EMP1 is significantly higher in the latter (93.1%) than in the former (16.3%) (18).